Diagnostic Testing
iXensor Confirms PixoTest® COVID-19 Antigen Test Detects Omicron and Other Key Variants of Concern
Both study results affirm that the PixoTest® COVID-19 Antigen Test can detect the latest Omicron variant effectively in addition to the previous confirmation on SARS-CoV-2 Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2).
Hologic’s COVID-19 Tests Detect Omicron Variant
“We fully expect that SARS-CoV-2 will continue to evolve, as that is the natural path for viruses,” said Kevin Thornal, president of the Diagnostic Solutions Division at Hologic. “We designed our assays with this in mind, and as a result, we are confident that the Omicron variant will not impact the performance of our assays.”
Hologic Announces European Launch of Genius™ Digital Diagnostics System for Cervical Cancer Screening
With the Genius Digital Diagnostics System, cutting-edge image analysis thoroughly interrogates every cell on a ThinPrep® Pap test image to curate a single view of the most clinically relevant objects.
Meridian Launches Innovative Air-Dryable™ qPCR Mixes Enabling Direct Detection of DNA or RNA from Urine Samples
Meridian developed these unique master mixes specifically to overcome the adverse effect of inhibitors present in crude urine samples that can affect the sensitivity of a molecular assay.
U.S. Based Pancreatic Cancer Action Network Informs Members About Immunovia’s Blood Test IMMray™ PanCan-d
"The Immunovia IMMray™ PanCan-d test is an important step for some patients to be diagnosed earlier, have more treatment options and live longer", said Julie Fleshman, JD, MBA, President and CEO of Pancreatic Cancer Action Network (PanCAN).
Sera Prognostics Partners With Anthem and HealthCore to Improve Outcomes for Preterm Babies
January 5, 2021
Sera Prognostics, Inc., The Pregnancy Company™, focused on improving maternal and neonatal health through innovative precision biomarker approaches, together with leading health...